2nd.md, founded in 2011, revolutionized access to specialist medical advice by providing virtual second opinions from leading U.S. medical experts. The platform connects individuals facing complex or challenging medical diagnoses with top physicians for consultations, aiming to improve diagnostic accuracy, optimize treatment plans, and empower patients to make informed healthcare decisions. In March 2021, 2nd.md was acquired by Accolade, Inc., a personalized healthcare company, to enhance Accolade's suite of advocacy and care navigation solutions. As part of Accolade (with its services now often referred to as Accolade Expert MD), 2nd.md's capabilities continue to help members navigate the complexities of the healthcare system and access high-quality care, particularly for significant health events.
Served as the central hub for 2nd.md's operations, encompassing technology development for its proprietary platform, physician network management, patient care coordination, sales, marketing, and corporate administrative functions before its integration with Accolade.
The Houston office was likely a modern office space within a larger commercial building, strategically chosen for accessibility and talent acquisition. It would have been equipped to support a significant tech-enabled service operation. Specific architectural details unique to 2nd.md's tenancy are not widely publicized.
Reportedly fostered a mission-driven culture focused on patient advocacy, innovation in healthcare delivery, and leveraging technology to democratize access to top medical expertise. The environment was likely dynamic and collaborative, characteristic of a rapidly growing healthcare technology company.
The Houston headquarters was pivotal in establishing 2nd.md as a prominent name in the virtual second opinion market. It was the nerve center for developing its unique service model, building its extensive network of specialist physicians, and driving its national growth.
While headquartered in the U.S. and primarily utilizing a network of U.S.-based medical specialists, 2nd.md's telehealth platform architecture enabled it to serve individuals and employees of multinational corporations globally, subject to applicable regional healthcare regulations. Its services were accessible virtually, effectively transcending the geographical limitations of physical office locations. Post-acquisition, as an integral part of Accolade, this global service capability is supported and potentially expanded through Accolade's established international client base and operational footprint.
12 Greenway Plaza, Suite 900 (Pre-acquisition primary address)
Houston
Texas
USA
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, 2nd.MD' leadership includes:
2nd.MD has been backed by several prominent investors over the years, including:
As 2nd.md was acquired by Accolade in March 2021 and its leadership and operational structure were fully integrated into Accolade, there are no publicly reported executive hires or exits specifically for the '2nd.md' entity in the last 12 months. Key former 2nd.md leaders transitioned into roles within Accolade or moved on at the time of or following the acquisition. Any recent executive changes relevant to the former 2nd.md services would be announced under Accolade's corporate communications.
Discover the tools 2nd.MD uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prior to its acquisition by Accolade, 2nd.md likely utilized common corporate email address patterns such as [first].[last]@2nd.md or [first_initial][last]@2nd.md. Following the integration into Accolade, direct emails to @2nd.md addresses may be redirected to Accolade's email system for a transition period, or could now be defunct. For current business communication related to services originating from 2nd.md (now Accolade Expert MD), it is advisable to use official Accolade, Inc. contact channels or ascertain the relevant Accolade email formats (e.g., typically [first].[last]@accolade.com).
Historically: [first].[last]@2nd.md or [f][last]@2nd.md
Format
example (historical): jane.doe@2nd.md or jdoe@2nd.md
Example
25%
Success rate
Accolade Investor Relations • May 4, 2023
In its fiscal year 2023 earnings report and subsequent investor communications, Accolade, Inc. emphasized the continued strong performance and successful integration of its expert medical opinion services, now branded Accolade Expert MD (which originated from the 2nd.md acquisition). These services are consistently highlighted as a key differentiator and value driver within Accolade's comprehensive healthcare navigation offerings, significantly impacting patient outcomes and healthcare cost management for its diverse client base....more
Accolade, Inc. Press Release • March 3, 2021
Accolade, Inc. announced definitive agreements to acquire 2nd.MD, a leader in expert medical opinions, for approximately $460 million in cash and stock. This strategic acquisition was aimed at integrating 2nd.MD's robust virtual consultation platform and extensive network of leading medical specialists into Accolade's personalized healthcare advocacy services, thereby enhancing its clinical depth and ability to guide members to the highest quality care....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including 2nd.MD, are just a search away.